Artal Group S.A. - GLYCOMIMETICS INC ownership

Quarter-by-quarter ownership
Artal Group S.A. ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q3 2023$12,884
-13.8%
8,589,0640.0%0.55%
+19.2%
Q2 2023$14,945
+38.1%
8,589,0640.0%0.46%
-28.0%
Q1 2023$10,822
-99.7%
8,589,064
+3335.6%
0.64%
+647.7%
Q2 2018$4,033,000
-23.5%
250,000
-23.1%
0.09%
+30.3%
Q1 2018$5,275,000
+25.7%
325,000
+30.0%
0.07%
+4.8%
Q4 2017$4,198,000
+48.2%
250,000
+23.5%
0.06%
+28.6%
Q3 2017$2,833,000
+25.4%
202,5000.0%0.05%
+25.6%
Q2 2017$2,260,000202,5000.04%
Other shareholders
GLYCOMIMETICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,000,000$5,220,0000.73%
NEA Management Company, LLC 4,764,440$8,290,1260.63%
Artal Group S.A. 8,589,064$14,9450.46%
BVF INC/IL 9,544,262$16,607,0160.46%
Sargent Investment Group, LLC 108,000$187,9200.05%
Intellectus Partners, LLC 73,475$127,8470.04%
XTX Topco Ltd 29,998$52,1970.01%
AXA S.A. 1,631,509$2,838,8260.01%
ACADIAN ASSET MANAGEMENT LLC 1,149,656$1,9990.01%
TOBIAS FINANCIAL ADVISORS, INC. 15,000$26,1000.01%
View complete list of GLYCOMIMETICS INC shareholders